IL13 and graft versus host disease: Although one study correlated IL-13 levels with GVHD severity in patients (94), transplantation experiments of IL-13-/- cells in an established mouse GVHD model resulted in increased mortality and decreased Th2 cytokine levels but elevated serum levels of TNF-α, a critical mediator of GVHD, in these mice (95).